I think the Canadian contribution through CIDA would be a drop in the bucket. We're talking about a lot of drugs over a long period of time, and the RFPs you're suggesting are not the way business is being done.
And I think it's for good reasons. Countries are responsible for their own health care. Botswana is responsible for addressing the needs of people in Botswana. If Botswana and a lot of countries are putting plans in place to address their HIV health issues, we should be supporting them as countries to do that. The main impact of this legislative change is creating opportunities, for the $8 billion that's out there to buy the drugs, to start their coming from Canada—making the competition happen.